In this white paper, Robert Smith provides a deep review of the EU advanced therapy medicinal products GMP guidance that comes into force on May 22, 2018. Robert outlines what is included in the guidance and takes a closer look at some of the important sections and what they mean to the manufacture of ATMPs.